{
  "id": [
    "32503232"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32503232"
  ],
  "pmcid": [
    "PMC7350001"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7350001"
      ]
    }
  ],
  "doi": [
    "10.3390/vaccines8020273"
  ],
  "title": [
    "Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses."
  ],
  "authorString": [
    "Stromberg ZR, Fischer W, Bradfute SB, Kubicek-Sutherland JZ, Hraber P."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Stromberg ZR"
          ],
          "firstName": [
            "Zachary R"
          ],
          "lastName": [
            "Stromberg"
          ],
          "initials": [
            "ZR"
          ],
          "authorId": [
            {
              "_": "0000-0002-1137-1128",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Physical Chemistry and Applied Spectroscopy, Chemistry Division, Los Alamos National Laboratory, Los Alamos, NM 505, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Fischer W"
          ],
          "firstName": [
            "Will"
          ],
          "lastName": [
            "Fischer"
          ],
          "initials": [
            "W"
          ],
          "authorId": [
            {
              "_": "0000-0003-4579-4062",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 505, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Bradfute SB"
          ],
          "firstName": [
            "Steven B"
          ],
          "lastName": [
            "Bradfute"
          ],
          "initials": [
            "SB"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Center for Global Health, Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico, Albuquerque, NM 505, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kubicek-Sutherland JZ"
          ],
          "firstName": [
            "Jessica Z"
          ],
          "lastName": [
            "Kubicek-Sutherland"
          ],
          "initials": [
            "JZ"
          ],
          "authorId": [
            {
              "_": "0000-0001-6215-4871",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Physical Chemistry and Applied Spectroscopy, Chemistry Division, Los Alamos National Laboratory, Los Alamos, NM 505, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Hraber P"
          ],
          "firstName": [
            "Peter"
          ],
          "lastName": [
            "Hraber"
          ],
          "initials": [
            "P"
          ],
          "authorId": [
            {
              "_": "0000-0002-2920-4897",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 505, USA."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-1137-1128",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0003-4579-4062",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0001-6215-4871",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-2920-4897",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics",
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "2"
      ],
      "volume": [
        "8"
      ],
      "journalIssueId": [
        "2963096"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "Vaccines"
          ],
          "ISOAbbreviation": [
            "Vaccines (Basel)"
          ],
          "medlineAbbreviation": [
            "Vaccines (Basel)"
          ],
          "NLMid": [
            "101629355"
          ],
          "ISSN": [
            "2076-393X"
          ],
          "ESSN": [
            "2076-393X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "Vaccinations are a crucial intervention in combating infectious diseases. The three neurotropic Alphaviruses, Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV) equine encephalitis viruses, are pathogens of interest for animal health, public health, and biological defense. In both equines and humans, these viruses can cause febrile illness that may progress to encephalitis. Currently, there are no licensed treatments or vaccines available for these viruses in humans. Experimental vaccines have shown variable efficacy and may cause severe adverse effects. Here, we outline recent strategies used to generate vaccines against EEEV, VEEV, and WEEV with an emphasis on virus-vectored and plasmid DNA delivery. Despite candidate vaccines protecting against one of the three viruses, few studies have demonstrated an effective trivalent vaccine. We evaluated the potential of published vaccines to generate cross-reactive protective responses by comparing DNA vaccine sequences to a set of EEEV, VEEV, and WEEV genomes and determining the vaccine coverages of potential epitopes. Finally, we discuss future directions in the development of vaccines to combat EEEV, VEEV, and WEEV."
  ],
  "affiliation": [
    "Physical Chemistry and Applied Spectroscopy, Chemistry Division, Los Alamos National Laboratory, Los Alamos, NM 505, USA."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "CB10547"
          ],
          "agency": [
            "Defense Threat Reduction Agency"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Antigens",
        "Vaccine",
        "DNA vaccine",
        "Alphavirus",
        "Venezuelan Equine Encephalitis Virus (Veev)",
        "Western Equine Encephalitis Virus (Weev)",
        "Eastern Equine Encephalitis Virus (Eeev)"
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.3390/vaccines8020273"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7350001"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7350001?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "N"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "refseq",
        "doi"
      ]
    }
  ],
  "dateOfCreation": [
    "2020-06-07"
  ],
  "firstIndexDate": [
    "2020-06-06"
  ],
  "fullTextReceivedDate": [
    "2020-07-28"
  ],
  "dateOfRevision": [
    "2020-07-23"
  ],
  "electronicPublicationDate": [
    "2020-06-03"
  ],
  "firstPublicationDate": [
    "2020-06-03"
  ]
}